Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 19Ovarian Neoplasms 12Fallopian Tube Neoplasms 9Stomach Neoplasms 4Vulvar Neoplasms 3Vaginal Neoplasms 2Peritoneal Neoplasms 2Mesothelioma, Malignant 2Carcinoma, Ovarian Epithelial 2Brenner Tumor 2Vomiting 1Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Sertoli-Leydig Cell Tumor 1Sarcoma 1Rhabdomyosarcoma 1Recurrent Uterine Corpus Carcinoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Penile Neoplasms 1Pelvic Neoplasms 1Ovarian gynandroblastoma 1Neoplasm Metastasis 1Nausea 1Lung Neoplasms 1Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Adenocarcinoma 1Liposarcoma 1HIV Infections 1

Interventions

Paclitaxel 2etoposide phosphate 1Taxes 1Platinum 1Nivolumab 1Immunoglobulin G 1Disulfides 1Cisplatin 1Carboplatin 1Bleomycin 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sertoli-Leydig Cell Tumor × Platinum × Gynecologic × Clear all
NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

GOG Foundation

Phase 2 Unknown
63 enrolled 16 charts
Gynecologic

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡